Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease

BACKGROUND: Recent clinical studies point to rapid and sustained clinical, cognitive, and behavioral improvement in both Alzheimer's disease and primary progressive aphasia following weekly perispinal administration of etanercept, a TNF-alpha inhibitor that acts by blocking the binding of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobinick, Edward L, Gross, Hyman
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500042/
https://www.ncbi.nlm.nih.gov/pubmed/18644112
http://dx.doi.org/10.1186/1471-2377-8-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500042/
https://www.ncbi.nlm.nih.gov/pubmed/18644112
http://dx.doi.org/10.1186/1471-2377-8-27

Ejemplares similares